ANI Pharmaceuticals Schedules Conference Call to Discuss Third Quarter 2020 Financial ResultsBusiness Wire • 10/29/20
ANI Pharmaceuticals Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)Business Wire • 09/10/20
ANI Pharmaceuticals, Inc. (ANIP) CEO Patrick Walsh on Q2 2020 Results - Earnings Call TranscriptSeeking Alpha • 08/09/20
ANI Pharmaceuticals Appoints Experienced Pharmaceutical Executives, Jeanne Thoma and Antonio “Tony” Pera to Board of DirectorsBusiness Wire • 08/06/20
ANI Pharmaceuticals Names Nikhil Lalwani as President and Chief Executive OfficerBusiness Wire • 08/03/20
ANI Pharmaceuticals Schedules Conference Call to Discuss Second Quarter 2020 Financial ResultsBusiness Wire • 07/30/20
Earnings Preview: ANI Pharmaceuticals (ANIP) Q2 Earnings Expected to DeclineZacks Investment Research • 07/29/20
Why the FDA's Drug Competition Action Plan Is Bad News for Generic Pharmaceutical StocksThe Motley Fool • 06/03/20
ANI Pharmaceuticals, Inc. (ANIP) CEO Arthur Przybyl on Q1 2020 Results - Earnings Call TranscriptSeeking Alpha • 05/09/20
ANI Pharmaceuticals (ANIP) Q1 Earnings and Revenues Surpass EstimatesZacks Investment Research • 05/07/20
ANI Pharmaceuticals, Inc. (ANIP) CEO Arthur Przybyl on Q4 2019 Results - Earnings Call TranscriptSeeking Alpha • 02/27/20
ANI Pharmaceuticals (ANIP) Q4 Earnings and Revenues Lag EstimatesZacks Investment Research • 02/27/20
ANI Pharmaceuticals (ANIP) Lags Q3 Earnings and Revenue EstimatesZacks Investment Research • 11/06/19
ANI Pharmaceuticals (ANIP) to Report Q3 Results: Wall Street Expects Earnings GrowthZacks Investment Research • 10/29/19
ANI Pharmaceuticals, Inc. (ANIP) CEO Arthur Przybyl on Q2 2019 Results - Earnings Call TranscriptSeeking Alpha • 08/07/19